New search Hide text from Guidelines
C CARDIOVASCULAR SYSTEMC10 LIPID MODIFYING AGENTS
| The DDDs are based on the treatment of hypercholesterolemia. |
C10A LIPID MODIFYING AGENTS, PLAIN
Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.
C10AX Other lipid modifying agents
This group comprises all cholesterol and triglyceride reducers, which cannot be classified in the preceding groups.
Sulodexide is classified in B01AB.
| The DDD for evolocumab is based on dosing every second week. |
| ATC code | Name | DDD | U | Adm.R | Note |
| C10AX01 | dextrothyroxine | 4 | mg | O | |
| C10AX02 | probucol | ||||
| C10AX03 | tiadenol | ||||
| C10AX05 | meglutol | ||||
| C10AX06 | omega-3-triglycerides incl. other esters and acids | ||||
| C10AX07 | magnesium pyridoxal 5-phosphate glutamate | ||||
| C10AX08 | policosanol | ||||
| C10AX09 | ezetimibe | 10 | mg | O | |
| C10AX10 | alipogene tiparvovec | ||||
| C10AX11 | mipomersen | ||||
| C10AX12 | lomitapide | 40 | mg | O | |
| C10AX13 | evolocumab | 10 | mg | P | |
| C10AX14 | alirocumab | 5.4 | mg | P | |
| C10AX15 | bempedoic acid |
Last updated: 2019-12-16